Pharmacokinetically and Clinician-Determined Adherence to an Antidepressant Regimen and Clinical Outcome in the TORDIA Trial

Mt. Sinai School of Medicine, New York, USA.
Journal of the American Academy of Child and Adolescent Psychiatry (Impact Factor: 6.35). 05/2011; 50(5):490-8. DOI: 10.1016/j.jaac.2011.01.018
Source: PubMed

ABSTRACT Nonadherence to antidepressant treatment may contribute to poor outcome and to suicidal adverse events in adolescent depression. We examine the relationship between adherence and both clinical response and suicidal events in participants in the Treatment of Resistant Depression in Adolescents (TORDIA) study.
The relationship between adherence to medication and clinical outcome was assessed in 190 treatment-resistant depressed adolescents who were randomized to one of four cells: switch to another selective serotonin reuptake inhibitor (SSRI), switch to venlafaxine, or either of these two medication switches plus cognitive behavioral therapy. Plasma levels of antidepressant drug and metabolites were determined after 6 and 12 weeks of treatment. A twofold or greater variation in the dose-adjusted concentration of drug plus metabolites (level/dose ratio [LDR]) was defined as nonadherence. Nonadherence was also determined by clinician pill counts (CPC) of the proportion of prescribed pills that were unused and was defined as having greater than 30% of the prescribed pills remaining.
LDR and CPC showed low concordance. LDR was unrelated to clinical response. CPC adherence was related to a higher response rate overall (adherent, 63.0% versus nonadherent, 47.2%, p = .03). Approximately half (50.8%) of the sample surveyed showed evidence of nonadherence by CPC. Neither measure of adherence was related to the occurrence of suicidal events or to the pace of decline in suicidal ideation.
Clinician pill counts may be a relevant measure of adherence that is related to outcome under formal clinical trial conditions in depressed adolescents. Nonadherence appears to be a common and significant source of treatment nonresponse. Clinical Trial Registration Information-Treatment of SSRI-Resistant Depression in Adolescents (TORDIA);; NCT00018902.

Download full-text


Available from: Neal D Ryan, Aug 16, 2015
  • Source
    • "antidepressant adherence in reducing rather than increasing future suicidal acts (Woldu et al., 2011). However, this association failed to remain significant in multivariate analysis for future attempt and was not significantly associated with the transition process in the univariate analysis either, highlighting the need for further studies in this area with larger sample size. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Our study aimed to examine the interplay between clinical and social predictors of future suicide attempt and the transition from suicidal ideation to suicide attempt in depressive disorders. Sixty-six Malaysian inpatients with a depressive disorder were assessed at index admission and within 1 year for suicide attempt, suicidal ideation, depression severity, life event changes, treatment history and relevant clinical and socio-demographic factors. One-fifth of suicidal ideators transitioned to a future suicide attempt. All future attempters (12/66) had prior ideation and 83% of attempters had a prior attempt. The highest risk for transitioning from ideation to attempt was 5 months post-discharge. Single predictor models showed that previous psychiatric hospitalization and ideation severity were shared predictors of future attempt and ideation to attempt transition. Substance use disorders (especially alcohol) predicted future attempt and approached significance for the transition process. Low socio-economic status predicted the transition process while major personal injury/illness predicted future suicide attempt. Past suicide attempt, subjective depression severity and medication compliance predicted only future suicide attempt. The absence of prior suicide attempt did not eliminate the risk of future attempt. Given the limited sample, future larger studies on mechanisms underlying the interactions of such predictors are needed.
    Psychiatry Research 12/2014; 220(5):867-873. DOI:10.1016/j.psychres.2014.08.055 · 2.68 Impact Factor
  • Journal of the American Academy of Child and Adolescent Psychiatry 05/2011; 50(5):435-7. DOI:10.1016/j.jaac.2011.02.006 · 6.35 Impact Factor
  • Journal of the American Academy of Child and Adolescent Psychiatry 10/2011; 50(10):1075-6; author reply 1076-7. DOI:10.1016/j.jaac.2011.07.004 · 6.35 Impact Factor
Show more